2,426
Participants
Start Date
January 17, 2022
Primary Completion Date
September 30, 2026
Study Completion Date
December 31, 2026
Treatment
For the treatment group, 200cc of 20% human albumin with 15 cc per kg of crystalloid will be administered over 1\~2h for initial fluid resuscitation. The treating physicians can choose the type of fluid, such as balanced fluid or isotonic saline.
Placebo
For the control group, 30 cc per kg of crystalloid will be administered according to the usual practice. The treating physicians can choose the type of fluid, such as balanced fluid or isotonic saline.
RECRUITING
Asan Medical Center, Seoul
Lead Sponsor
Samsung Medical Center
OTHER
Gangnam Severance Hospital
OTHER
Chungnam National University Hospital
OTHER
Seoul National University Hospital
OTHER
Seoul National University Bundang Hospital
OTHER
SMG-SNU Boramae Medical Center
OTHER
Hanyang University
OTHER
Korea University Ansan Hospital
OTHER
Asan Medical Center
OTHER